Drug intelligence / Profile preview

methionine

Development stage
Phase 3
Lead developer
Evonik
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Methionine is an essential amino acid required for protein synthesis and numerous metabolic processes in the human body. It serves as a principal supplier of sulfur and is involved in methylation reactions by forming S-adenosylmethionine (SAM), which acts as a universal methyl donor for over 50 transmethylation reactions. Methionine exhibits antioxidant properties, helps detoxify harmful substances such as heavy metals and acetaminophen metabolites, regulates lipid metabolism by increasing hepatic lecithin production and reducing liver fat accumulation, and can acidify urine to relieve skin irritation from incontinence. It also plays roles in growth, repair of tissues, DNA methylation regulation, ammonia detoxification (by creating ammonia-free urine), and may have anti-inflammatory effects through inhibition of NF-κB signaling pathways[1][6][7]. Methionine is used clinically to treat conditions such as liver disease (including fatty liver), homocystinuria (cystathionine beta-synthase deficiency), osteoporosis, cardiovascular disease risk management due to its effect on homocysteine levels, depression, Alzheimer’s disease support therapy, schizophrenia adjunctive therapy (historically at high doses), pancreatitis support care[5], prevention of neural tube defects during pregnancy[2], control of strong urine odor or diaper rash via urinary acidification[3][4], and protection against radiation or oxidative stress damage[7]. Excessive intake can cause adverse effects including nausea/vomiting/headache at high doses; it may increase blood homocysteine levels—a risk factor for cardiovascular disease—and should be avoided by individuals with certain metabolic disorders or severe liver dysfunction.

Brand names
ME-500ME500ME 500
Other names
a-amino-g-methylthiol-n-butyric acidracemethionine
02

Targets

MAT (Monoamine transporters)GLUL (Glutamine synthetase)MTHFR (Methylenetetrahydrofolate reductase)

Beyond the preview

Go deeper on methionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methionine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call